fashion -WSS

fashion

author：fashion 2025-09-28 01:37:15 - browse：4

A drug developed by the biotech firm BridgeBio to treat an increasingly common heart condition succeeded in its main goal in a clinical trial, the company said Monday, and also pointed to potential reductions in hospitalization and death.

The results may give the medicine, acoramidis, a path to the market after a failure that led its maker’s stock to plunge in December 2021.

In the time since the initial failure, a rival Pfizer drug has become even more entrenched and another medicine, from Alnylam Pharmaceuticals, has had a successful clinical readout in the heart disease, known as ATTR-CM, in which a defective protein leads clumps to build up in the heart.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Cano Health’s bankruptcy is a warning for Medicare Advantage

focus

hotspot

WSS

Surgery pushed Ben Carson to fame

Gene therapy denied for Afghan refugee whose father aided U.S.

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Global cancer cases to surge 77% by 2050, WHO report says

Cano Health’s bankruptcy is a warning for Medicare Advantage

Problems with a popular proposal to regulate AI in health care

leisure time

fashion

explore

The high cost of giving birth even with insurance

A protest over insulin prices is seen as a fight for life

Wildfire smoke exposes gaps in outdoor worker protections

Arena BioWorks launches in Cambridge to speed drug discovery

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

State Dept. review finds Biden bears some blame for Afghanistan failures

What’s missing from the debate over nursing home staff minimums

Drug repurposing or repositioning? The language matters

Profiling embryos to choose those with higher IQs is almost a reality

entertainment

STAT Virtual Event: JPM Recap, Live!

340B reform proposal comes out of Senate working group

Fauci's latest grilling in Congress: 9 hours, behind closed doors

AI gets buy

Updated Covid vaccine has 54% effectiveness, new study suggests

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

focus

hotspot

hotspot

leisure time